Application of montmorillonite in bentonite as a pharmaceutical excipient in drug delivery systems
- 21 May 2016
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Pharmaceutical Investigation
- Vol. 46 (4), 363-375
- https://doi.org/10.1007/s40005-016-0258-8
Abstract
Montmorillonite is a multifunctional clay mineral and a major component of bentonite. Montmorillonite has been used in various industrial and pharmaceutical fields due to its unique characteristics, which include swelling and adsorption. The high adsorption capacity of montmorillonite contributes to increase drug entrapment and sustained-release of drugs. Montmorillonite generally sustains drug release in many formulations by strongly adsorbing to the drug. In addition, montmorillonite enhances the dissolution rate and bioavailability of hydrophobic drugs. Moreover, montmorillonite was applied to form composites with other polymer-based delivery systems. Thus, montmorillonite could be applied to formulate diverse drug delivery systems to control and/or improve the pharmaceutical properties of drugs, including solubility, dissolution rate, and absorption. In this review, perspectives of applying montmorillonite as a pharmaceutical excipient in drug delivery systems are discussed.Keywords
This publication has 107 references indexed in Scilit:
- Drug Solubility: Importance and Enhancement TechniquesISRN Pharmaceutics, 2012
- Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agentsInternational Journal of Nanomedicine, 2011
- Efficacy of Diosmectite (Smecta)®in the Treatment of Acute Watery Diarrhoea in Adults: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group StudyGastroenterology Research and Practice, 2011
- Controlled release of ofloxacin from chitosan–montmorillonite hydrogelApplied Clay Science, 2010
- Intestine-Specific, Oral Delivery of Captopril/Montmorillonite: Formulation and Release KineticsNanoscale Research Letters, 2010
- Understanding specific and nonspecific toxicities: a requirement for the development of dendrimer‐based pharmaceuticalsWIREs Nanomedicine and Nanobiotechnology, 2010
- Montmorillonite-alginate composites as a drug delivery system: Intercalation and In vitro release of diclofenac sodiumIndian Journal of Pharmaceutical Sciences, 2010
- Protein and peptide drug delivery: Oral approachesIndian Journal of Pharmaceutical Sciences, 2008
- Structure and swelling of poly(acrylic acid) hydrogels: effect of pH, ionic strength, and dilution on the crosslinked polymer structurePolymer, 2004
- Thermal studies of pharmaceutical-clay systems Part I. Montmorillonite-based systemsThermochimica Acta, 1996